Idenix Pharmaceuticals Inc (IDIX) financial statements (2021 and earlier)

Company profile

Business Address 320 BENT STREET
CAMBRIDGE, MA 02141
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments122231
Cash and cash equivalents122231
Restricted cash and investments12
Receivables11
Prepaid expense and other current assets4
Other current assets5
Total current assets:130238
Noncurrent Assets
Property, plant and equipment33
Long-term investments and receivables56
Due from related parties56
Other noncurrent assets3
Prepaid expense and other noncurrent assets4
Total noncurrent assets:1113
TOTAL ASSETS:141251
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2018
Accounts payable86
Accrued liabilities99
Employee-related liabilities33
Other liabilities00
Other undisclosed current liabilities(2)(2)
Total current liabilities:1816
Noncurrent Liabilities
Liabilities, other than long-term debt1412
Deferred revenue and credits44
Other liabilities98
Other undisclosed noncurrent liabilities34
Total noncurrent liabilities:1716
Total liabilities:3532
Stockholders' equity
Stockholders' equity attributable to parent106219
Common stock00
Additional paid in capital935927
Accumulated other comprehensive income10
Accumulated deficit(830)(708)
Total stockholders' equity:106219
TOTAL LIABILITIES AND EQUITY:141251

Income statement (P&L) ($ in millions)

12/31/2013
12/31/2012
Revenues070
Cost of revenue(1)(3)
Gross profit:(0)67
Operating expenses(125)(105)
Other undisclosed operating income23
Operating loss:(124)(35)
Nonoperating income13
Loss from continuing operations before income taxes:(122)(32)
Income tax benefit00
Net loss available to common stockholders, diluted:(122)(32)

Comprehensive Income ($ in millions)

12/31/2013
12/31/2012
Net loss:(122)(32)
Comprehensive loss:(122)(32)
Other undisclosed comprehensive income, net of tax, attributable to parent00
Comprehensive loss, net of tax, attributable to parent:(122)(32)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: